Phase 2
N=56
Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting
Coronary Artery Bypass Grafting · Cardiopulmonary Bypass · Reperfusion Injury
Bottom Line
View on ClinicalTrials.gov: NCT00246740 ↗Enrolled (actual)
56
Serious AEs
0.0%
Results posted
Dec 2017
Primary outcome: Primary: Left Ventricular Stroke Work Index (LVSWI) — 42; 43; 29; 28 g*m/m2
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Periostat (Drug); Placebo Oral Tablet (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Alberta
- Primary completion
- May 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Left Ventricular Stroke Work Index (LVSWI) |
42; 43; 29; 28; 30; 29 | — |
| SECONDARY Cardiac Matrix Metalloproteinase-9 Activity in Right Atrial Biopsies at 10 Minutes Reperfusion |
.75; 1.56; .44; 1.63 | — |
| SECONDARY Cardiac Matrix Metalloproteinase-2 Activity in Right Atrial Biopsies at 10 Minutes Reperfusion |
.36; .24; .42; .25 | — |
| SECONDARY Venous Plasma Cardiac Matrix Metalloproteinase-9 Activity Before and After Reperfusion |
.07; .11; .06; .12; 1.22; 1.37 | — |
| SECONDARY Venous Plasma Cardiac Matrix Metalloproteinase-2 Activity Before and After Reperfusion |
.99; 1.06; .93; .96; 1.01; 1.05 | — |
| SECONDARY Venous Plasma Concentration of Troponin-I |
1.23; 1.07; 1.39; 1.78 | — |
| SECONDARY Cleaved TroponinI/GAPDH Ratios in Right Atrial Biopsy |
1.1318; 2.3454; 1.5195; 2.1893 | — |
| SECONDARY Venous Plasma Concentration of C-reactive Protein |
5.7; 10; 5.7; 9.9; 4; 7.5 | — |
| SECONDARY Venous Plasma Concentration of IL-6 |
5.7; 1.9; 5.6; 2.8; 15.4; 7.3 | — |
Summary
The purpose of this study is to determine whether doxycycline (Periostat) at a sub-antimicrobial dose will decrease reperfusion injury after coronary artery bypass grafting (CABG) surgery with cardiopulmonary bypass (CPB).
Eligibility Criteria
Inclusion Criteria
- Written informed consent
- Aged 18 through 80 years, inclusive
- Scheduled for primary CABG surgery with CPB
Exclusion Criteria
- Females of childbearing potential
- Emergency CABG
- Previous sternotomy
- Planned simultaneous surgery (i.e. valve repair or carotid endarterectomy)
- Myocardial infarction within 48 hours
- Pre-operative atrial fibrillation
- Pre-operative ventricular pacing or left bundle branch block (LBBB)
- Known hypersensitivity to tetracycline class antibiotics
- Renal failure requiring dialysis
Data sourced from ClinicalTrials.gov (NCT00246740). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.